Abstract:3D bioprinting is a powerful technique for engineering tissues used to study cell behavior and tissue properties in vitro. With the right formulation and printing parameters, bioinks can provide native biological and mechanical cues while allowing for versatile 3D structures that recapitulate tissue-level organization. Bio-based materials that support cellular adhesion, differentiation, and proliferation - including gelatin, collagen, hyaluronic acid, and alginate - have been successfully used as bioinks. In particular, decellularized extracellular matrix (dECM) has become a promising material with the unique ability to maintain both biochemical and topographical micro-environments of native tissues. However, dECM has shown technical limitations for 3D printing (3DP) applications posed by its intrinsically low mechanical stability. Herein, we report hydrogel bioinks composed of partially digested, porcine cardiac decellularized extracellular matrix (cdECM), Laponite-XLG nanoclay, and poly(ethylene glycol)-diacrylate (PEG-DA). The Laponite facilitated extrusion-based 3DP, while PEG-DA enabled photo-polymerization after printing. Improving upon previously reported bioinks derived from dECM, our bioinks combine extrudability, shape fidelity, rapid cross-linking, and cytocompatibility in a single formulation (> 97% viability of encapsulated human cardiac fibroblasts and > 94% viability of human induced pluripotent stem cell derived cardiomyocytes after 7 days). The compressive modulus of the cured hydrogel bioinks was tunable from 13.4-89 kPa by changing the concentration of PEG-DA in the bioink formulation. Importantly, this span of mechanical stiffness encompasses ranges of tissue stiffness from healthy (compressive modulus ~5-15 kPa) to fibrotic (compressive modulus ~30-100 kPa) cardiac tissue states. The printed constructs demonstrated shape fidelity, adaptability to different printing conditions, and high cell viability following extrusion and photo-polymerization, highlighting the potential for applications in modeling both healthy and fibrotic cardiac tissue.

Three-Dimensional Bioprinting of Decellularized Extracellular Matrix-Based Bioinks for Tissue Engineering

Recent Advances in Decellularized Extracellular Matrix-Based Bioinks for 3D Bioprinting in Tissue Engineering

Recent Advances in Decellularized Matrix-Derived Materials for Bioink and 3D Bioprinting

Strategies for improving the 3D printability of decellularized extracellular matrix bioink

Three-dimensional bioprinting with decellularized extracellular matrix-based bioinks in translational regenerative medicine

3D Bioprinting: A Novel Avenue for Manufacturing Tissues and Organs

Designing Decellularized Extracellular Matrix‐Based Bioinks for 3D Bioprinting

Decellularized extracellular matrix: A step towards the next generation source for bioink manufacturing.

Inkjet 3D Bioprinting for Tissue Engineering and Pharmaceutics

Rise of tissue- and species-specific 3D bioprinting based on decellularized extracellular matrix-derived bioinks and bioresins

An Overview of Extracellular Matrix-Based Bioinks for 3D Bioprinting

Emerging Frontiers in 3D Bioprinting: Harnessing Decellularized Matrix Bioink for Advancements in Musculoskeletal Tissue Engineering

Decellularized extracellular matrix for three-dimensional bioprinted in vitro disease modeling

Extracellular‐Matrix‐Reinforced Bioinks for 3D Bioprinting Human Tissue

Directly Coaxial 3D Bioprinting of Large-Scale Vascularized Tissue Constructs.

Engineering Bio-Inks for 3D Bioprinting Cell Mechanical Microenvironment

3D bioprinting of mechanically tuned bioinks derived from cardiac decellularized extracellular matrix

Advances in Photocrosslinkable Materials for 3D Bioprinting

Bioinks for bioprinting using plant-derived biomaterials

3D Bioprinting of Human Tissues: Biofabrication, Bioinks, and Bioreactors

Current Advances in 3D Bioprinting Technology and Its Applications for Tissue Engineering